Sullivan Mark — SEC insider filings
SEC reporting owner CIK 1331843. 21 insider filings on record with FilingPulse; latest filed 2026-09-29.
Transaction summary — filings shown
Covers all 21 filings on record, filed 2021-02-23 to 2026-09-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 12 filings — 364,234 shares, $2,019,200 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 13,008 shares @ $45.03 ($585,750) in Definium Therapeutics, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Definium Therapeutics, Inc. (DFTX) | Chief Legal Officer | 17 | — | 10 legs · 105,185 sh · $1,867,126 | 7 |
| Sesen Bio, Inc. (SESN) | General Counsel & Secretary | 4 | — | 4 legs · 259,049 sh · $152,074 | 4 |
Insider filings — Sullivan Mark
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-29 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 14,051 @ $36.57 | EDGAR |
| 2026-09-14 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2026-08-12 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-06-26 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 13,008 @ $45.03 | EDGAR |
| 2026-06-22 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 62,500 @ $0 | EDGAR |
| 2026-03-26 | 4 | Definium Therapeutics, Inc. (DFTX) | Sale (S): 10,702 @ $18.47 | EDGAR |
| 2026-02-05 | 4 | Definium Therapeutics, Inc. (DFTX) | Grant/award (A): 125,000 @ $0 | EDGAR |
| 2025-12-29 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 11,276 @ $13.15 | EDGAR |
| 2025-09-26 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 11,278 @ $9.77 | EDGAR |
| 2025-06-26 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 11,491 @ $6.80 | EDGAR |
| 2025-03-26 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 6,576 @ $6.74 | EDGAR |
| 2025-03-13 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/award (A): 150,000 @ $0 | EDGAR |
| 2024-12-27 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 4,519 @ $7.43 | EDGAR |
| 2024-09-25 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 4,430 @ $5.98 | EDGAR |
| 2024-06-25 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Sale (S): 17,854 @ $7.22 | EDGAR |
| 2024-02-29 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2023-04-14 | 4 | Mind Medicine (MindMed) Inc. (MNMD) | Grant/award (A): 200,000 @ $0 | EDGAR |
| 2023-03-06 | 4 | Sesen Bio, Inc. (SESN) | Sale (S): 100,978 @ $0.59 · Option exercise (M): 185,000 @ $0.59 · Sale (S): 73,361 @ $0.59 · Option exercise (M): 113,175 @ $0.59 · Sale (S): 44,879 @ $0.59 | EDGAR |
| 2023-02-23 | 4 | Sesen Bio, Inc. (SESN) | Sale (S): 39,831 @ $0.59 | EDGAR |
| 2022-02-23 | 4 | Sesen Bio, Inc. (SESN) | Grant/award (A): 339,525 @ $0 | EDGAR |
| 2021-02-23 | 4 | Sesen Bio, Inc. (SESN) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-02-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1331843 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs